Lithocholic Acid: UDCA EP Impurity C Limit and Test
Share
Lithocholic acid is impurity C of ursodeoxycholic acid in the European Pharmacopoeia. It is limited to 0.1%, and it is the only one of the nine lettered UDCA impurities that is tested by a method of its own — thin-layer chromatography, separate from the liquid-chromatography related-substances test that covers everything else.
That difference is not a formatting detail. It changes what a certificate of analysis has to show, and it is one of the most concrete things a buyer can check.
This article covers what lithocholic acid is, why the monograph treats it differently from its neighbours, where it comes from in a UDCA process, and how to read the impurity C line on a certificate without being misled by the figures that circulate online. Values are from the Ph. Eur. monograph for ursodeoxycholic acid (monograph 1275) and the companion CDCA monograph (1189).
The one UDCA impurity with a test of its own
The related-substances section of the UDCA monograph is a liquid-chromatography method. It resolves the named impurities, applies individual limits to each of the lettered ones, and applies common ceilings to unspecified and total impurities.
Impurity C sits outside that method. It has a dedicated limit test, run by thin-layer chromatography, with its own reference standard and its own limit of 0.1%. When you read a UDCA certificate, the impurity C result is not one line among many in the same test — it is a separate test, and it should be reported as one.
The practical consequence is simple: a certificate that reports a total impurities percentage and no separate lithocholic acid line is missing a required result, not saving space.
What lithocholic acid actually is
The identity data are worth setting out plainly, because “impurity C” and “lithocholic acid” are the same thing being named two different ways.
| Field | Value |
|---|---|
| EP letter (UDCA monograph) | C |
| Chemical name | 3α-hydroxy-5β-cholan-24-oic acid |
| Common name | Lithocholic acid (LCA) |
| CAS number | 434-13-9 |
| Molecular formula | C24H40O3 |
| Limit in the UDCA monograph | Not more than 0.1% |
| Method | Thin-layer chromatography (dedicated limit test) |
| Also found in | The CDCA monograph (1189), as its impurity C at the same 0.1% limit |
Compare that formula with the ones around it. UDCA and chenodeoxycholic acid are both C24H40O4 — a carboxyl group plus two hydroxyls. Lithocholic acid is C24H40O3: one oxygen fewer. It is what remains when the 7-hydroxyl group is removed entirely, leaving a single hydroxyl at C-3.
One hydroxyl instead of two is a small change on paper and a large one in behaviour. Fewer hydroxyls means a more lipophilic molecule, and lithocholic acid is the most lipophilic of the common bile acids. That single fact explains almost everything about how the monograph treats it.
Why the monograph singles it out
Pharmacopoeial impurity limits are set by toxicological risk, not by how easy a compound is to make or to remove. Among the bile acids that arise in UDCA production, lithocholic acid is the one that carries the profile regulators want controlled at the lowest level.
The monograph’s response is proportionate to that: where the other impurities are held under a general chromatographic method with limits in the 0.1% to 1.0% range, impurity C is given a dedicated, lower-limit test so that it cannot be absorbed into a larger total figure. A compound with an individual test cannot be hidden inside a sum.
This is worth stating carefully, because it is easy to over-read. The presence of a limit is not an allegation about a specific supplier’s material, and it is not a statement about what the compound does in the body. It is a control decision: this impurity gets its own number because the pharmacopoeia judges that it should not be averaged away.
Where lithocholic acid comes from
Lithocholic acid is the end point of removing hydroxyl groups from the bile-acid skeleton. In the UDCA context it arises mainly by 7-dehydroxylation — the loss of the C-7 hydroxyl that distinguishes UDCA and CDCA from lithocholic acid.
That pathway shows up in two places a supplier has to manage. The first is chemical: conditions that are harsh enough to strip a hydroxyl, or side reactions during oxidation and reduction steps, can push material toward the monohydroxy skeleton. The second is biological: lithocholic acid is also a normal microbial metabolite in the gut, which is why it is a well-known bile acid quite apart from its role as an impurity.
Because the impurity is structurally the “simplest” of the set, it is also one of the easiest to form and one of the least forgiving to carry. That combination is why the monograph does not let it ride inside a total.
The 0.1% limit in context
Impurity C is the strictest of the individually specified limits in the UDCA monograph. Setting the lettered limits side by side makes the relative weighting visible.
| Impurity | Identity | Limit in UDCA (1275) |
|---|---|---|
| A | Chenodeoxycholic acid | Not more than 1.0% |
| B | Cholic acid | Not more than 0.5% |
| C | Lithocholic acid | Not more than 0.1% |
| Unspecified | Any unnamed impurity | Not more than 0.10% each |
| Total | All impurities | Not more than 1.5% |
| Disregard limit | Reporting threshold | 0.05% |
Two readings follow. First, the 0.1% ceiling for impurity C is ten times tighter than the 1.0% allowed for impurity A, even though chenodeoxycholic acid is also the principal starting material — the two limits are answering different questions. Second, 0.1% happens to equal the unspecified-impurity ceiling, which is a coincidence that causes confusion: the two are separate controls with separate consequences.
The TLC method, and why it is not HPLC
Running a single impurity on thin-layer chromatography while everything else goes through liquid chromatography looks inconsistent until you consider what the test is for.
A TLC limit test is a comparison against a reference spot: the sample’s impurity C spot must not be more intense than a reference spot at the limit. It is a visual, threshold-based technique rather than a quantitative assay. For a compound that needs to be held to a low ceiling and kept out of a total, a dedicated limit test of this kind is a direct way to enforce that ceiling.
For a buyer, the method itself is the check. The certificate should name the method, and for impurity C that method should be the dedicated test, not an inference from the related-substances run. If a supplier reports a lithocholic acid figure without saying which method produced it, that is the question to ask.
The numbers that get quoted wrong
Three figures from this part of the monograph circulate online in versions that do not match the pharmacopoeia. They are worth knowing in their correct form.
| Parameter | Ph. Eur. value | Version often seen |
|---|---|---|
| Impurity C limit | 0.1% | 0.5% — appears when a cholic-acid limit is quoted for the wrong letter |
| Impurity A limit | 1.0% | 0.5% — a figure borrowed from another letter |
| Disregard limit | 0.05% | 0.1% — a tenfold error in what gets counted |
The pattern behind these errors is the same one that runs through bile-acid documentation generally: letters and limits get copied between rows, and between products, until a table looks plausible but no longer matches any single monograph. The correct form is worth memorising precisely because the wrong form is so common.
How to read the impurity C line on a COA
- Look for a line that exists at all. Impurity C is a required result. If only a total impurities figure is printed, ask for the separate line.
- Check the limit stated. It should read 0.1%. A line showing a different ceiling is being reported against something other than the monograph.
- Check the method is named. Impurity C is a dedicated limit test. A certificate that does not say so is incomplete.
- Read it against the disregard limit. Peaks at or below 0.05% are not counted. A result reported as “not detected” and a result reported as “below 0.05%” are not the same statement.
- Keep it separate from the total. Impurity C is individually controlled; it should not be folded into the total-impurities figure on the certificate.
- Cross-check the assay. Content on the dried basis should sit between 99.0% and 101.0%. An assay given on an undried basis is measuring something else.
Questions buyers ask
What is UDCA EP impurity C?
Lithocholic acid, 3α-hydroxy-5β-cholan-24-oic acid, CAS 434-13-9. It is limited to 0.1% under a dedicated thin-layer chromatography test.
Why does lithocholic acid have its own test?
It is the only UDCA impurity the monograph holds under a separate, dedicated limit test rather than the general related-substances method, so that it cannot be absorbed into a total figure.
What is the difference between impurity C and impurity E?
Impurity C is lithocholic acid, which has a single hydroxyl at C-3. Impurity E is deoxycholic acid, which carries hydroxyls at C-3 and C-12. They are different molecules with different limits.
Is lithocholic acid an impurity in CDCA as well?
Yes. In the CDCA monograph (1189) it is also impurity C, at the same 0.1% limit. The letter is shared here because the compounds happen to match at position C in both monographs.
Is 0.1% the same as the unspecified-impurity limit?
The figures match, but they are different controls. Impurity C is a specified impurity identified by name; the 0.10% figure for unspecified impurities applies to any single unnamed peak. They are reported separately.
Can a certificate pass without a lithocholic acid result?
Not against the monograph. The separate impurity C result is required, so its absence is a documentation gap regardless of what the total impurities figure says.
What to ask a supplier about impurity C
The limit itself is fixed by the pharmacopoeia; a buyer cannot negotiate it down. What a buyer can do is make sure the documentation in front of them reflects it honestly. Three questions do most of the work.
Ask for the impurity C result as its own line, with the method named and the limit stated. Ask whether the reported figure is a measured value or a “below the disregard limit” statement. And ask for the related-substances block alongside it, so the single impurity and the total can be read together rather than in isolation.
If you want the wider picture, the nine lettered impurities are mapped letter by letter in the full A–I impurity reference, and the surrounding identity and purity parameters are gathered in a full UDCA specification. Our ursodeoxycholic acid grade is described with those parameters, and you can request a quotation against your own acceptance criteria.
The limit and its separate test are those of the current European Pharmacopoeia monograph for ursodeoxycholic acid, published by the European Directorate for the Quality of Medicines. Impurity control for pharmaceutical substances more broadly follows the ICH quality guidelines, and the identity of the named reference substances can be confirmed against a published catalogue such as that of the United States Pharmacopeia.
This article describes pharmacopoeial requirements and analytical interpretation only. It is not a statement of therapeutic use, and it does not set out commercial guarantees. Always work from the pharmacopoeia edition in force at the time of your release.
Frequently asked questions
Why does lithocholic acid have its own line on a UDCA certificate?
Because it is a named impurity with an individual limit rather than something absorbed into a total. It is among the harder bile-acid impurities to purge, which is why monographs control it separately. A supplier who reports it by name with a method attached is telling you they measure it deliberately.
Where does lithocholic acid in UDCA come from?
From the starting-material family carried through the route and from isomerisation during processing. Its level is a process statement more than a cleaning statement. That is why the trend across batches is worth more than any single number on any single certificate.
What order of limit applies?
Read the monograph of the destination pharmacopoeia rather than quoting from memory. The individual limit sits well below one percent, and the certificate should show both the limit and the method, not just a result. A result without its limit is a number without a sentence.
Is one good LCA result enough to qualify a supplier?
No. One result at a fraction of the limit could reflect a good process or a lucky batch. Ask for the last several batches and look at the spread. A supplier with consistent results slightly above yours and no drift is a better bet than one brilliant number.
Does the related-substances method actually see LCA at the levels specified?
Only if its limit of quantification sits below the limit. That is the technical question behind every "not detected" on the impurity table. If the COA does not state the LOQ, ask for it in writing; a method that cannot see the limit cannot report against it.
One supplier reports 0.008%, another reports ND. Which is better?
The one that defines the ND. A not-detected without a stated LOQ is not comparable to a number, and pretending otherwise builds a comparison on nothing. Ask what the ND means, at what quantification limit, by which method, and then the two certificates can be read side by side.